Background/AimsHepatocellular carcinoma (HCC), accounting for 75-85% of primary liver cancer cases, is the third leading cause of cancer-related death worldwide. The purpose of this research was to examine the tumor immune microenvironment (TIME) in HCC.MethodsWe investigated the HCC TIME by integrated analysis of single-cell and bulk-tissue sequencing data to reveal the landscape of major immune cell types.ResultsRegulatory T(Treg) cells were found to be specifically distributed in the TIME of HCC. Several immune checkpoints, including TNFRSF4, TIGIT and CTLA4, were found to be uniquely overexpressed in Treg cells, and the glycolysis/gluconeogenesis pathway was enriched in Treg cells. We also discovered the presence of two NK-cell subsets ...
Clonal evolution of a tumor ecosystem depends on different selection pressures that are principally ...
Immune associated cells in the microenvironment have a significant impact on the development and pro...
Abstract In hepatocellular carcinoma (HCC), γδ T cells participate in mediating the anti‐tumour resp...
Hepatocellular carcinoma (HCC) is the most common liver tumor and among the deadliest cancers worldw...
BACKGROUND: Exhausted T cells and regulatory T cells (Tregs) comprise diverse subsets of tumor immun...
Zeyu Zhang, Zhiming Wang, Yun Huang Department of Hepatobiliary Surgery, Xiangya Hospital, Central S...
IntroductionMounting evidence has revealed that the interactions and dynamic alterations among immun...
The development of immunotherapy for solid tumours has boosted interest in the contexture of tumour ...
BACKGROUND & AIMS: Agents that induce an immune response against tumors by altering T-cell regulatio...
The liver is a central immunomodulator that ensures a homeostatic balance between protection and imm...
Background: The antitumor immune response may play a major role in the clinical outcome of hepatocel...
Background & aims: Despite recent translation of immunotherapies into clinical practice, the immunob...
Hepatocellular carcinoma (HCC) is the fourth leading cause of cancer-related death worldwide. HCC pa...
Systematic interrogation of tumor-infiltrating lymphocytes is key to the development of immunotherap...
Hepatocellular carcinoma (HCC) is a highly prevalent primary liver carcinoma and the main cause of d...
Clonal evolution of a tumor ecosystem depends on different selection pressures that are principally ...
Immune associated cells in the microenvironment have a significant impact on the development and pro...
Abstract In hepatocellular carcinoma (HCC), γδ T cells participate in mediating the anti‐tumour resp...
Hepatocellular carcinoma (HCC) is the most common liver tumor and among the deadliest cancers worldw...
BACKGROUND: Exhausted T cells and regulatory T cells (Tregs) comprise diverse subsets of tumor immun...
Zeyu Zhang, Zhiming Wang, Yun Huang Department of Hepatobiliary Surgery, Xiangya Hospital, Central S...
IntroductionMounting evidence has revealed that the interactions and dynamic alterations among immun...
The development of immunotherapy for solid tumours has boosted interest in the contexture of tumour ...
BACKGROUND & AIMS: Agents that induce an immune response against tumors by altering T-cell regulatio...
The liver is a central immunomodulator that ensures a homeostatic balance between protection and imm...
Background: The antitumor immune response may play a major role in the clinical outcome of hepatocel...
Background & aims: Despite recent translation of immunotherapies into clinical practice, the immunob...
Hepatocellular carcinoma (HCC) is the fourth leading cause of cancer-related death worldwide. HCC pa...
Systematic interrogation of tumor-infiltrating lymphocytes is key to the development of immunotherap...
Hepatocellular carcinoma (HCC) is a highly prevalent primary liver carcinoma and the main cause of d...
Clonal evolution of a tumor ecosystem depends on different selection pressures that are principally ...
Immune associated cells in the microenvironment have a significant impact on the development and pro...
Abstract In hepatocellular carcinoma (HCC), γδ T cells participate in mediating the anti‐tumour resp...